Rabbit polyclonal antibody to human Insulin-like 3 (115-131): Affinity purified

ZZZZ_Status (Active, Disc) : Discontinued

 

AA_Supplier Name : Biosensis

 

Alternative_Name (Other Names) :

Leydig insulin-like peptide; Ley-I-L; Relaxin-like factor; INSL3; RLF; RLNL;

 

Antibody_Isotype
(Antibody only) :

 

Application_Details :

Immunohistochemistry (IHC) and Western Blotting (WB). A concentration of 1.0 µg/mL is recommended for WB. Human INSL3 (precursor) has a predicted length of 131 residues and MW of 14 kDa. A concentration of 1.0 µg/mL is recommended to detect the protein in formalin fixed and paraffin embedded tissues. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.

 

Background_Info :

 

Clone_Name
(AB only, monoclonals) :

 

Datasheet_Link : http://www.biosensis.com/pdf_datasheet.php?products_id=537

 

Description (Long Description) : 

The Insulin-like 3 (INSL3) precursor is cleaved into 2 chains; Insulin-like 3 B and Insulin-like 3 A. The protein is a heterodimer of a B chain and an A chain linked by two disulfide bonds. INSL3 is expressed in prenatal and postnatal Leydig cells as well in the corpus luteum, trophoblast, fetal membranes and breast.

 

Expiry_Date : 

12 months after purchase

 

Format (Form) : 

Lyophilized with 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3

 

Immunogen (Antigen) :A synthetic peptide corresponding to a region (115-131) from human Insulin-like 3 (INSL3). To enhance the immunological response, this peptide was coupled to carrier protein BSA.

 

Kit_Components :

 

MSDS (File name) :